Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Atherosclerosis. Supplements
|
January 30, 2013
Current situation of lipoprotein apheresis in Saxony
U Julius, K Taseva, S Fischer, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a)-an interdisciplinary challenge
U Julius, S Tselmin, U Schatz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 29, 2014
[Lipoprotein(a): a risk factor for atherosclerosis]
S Fischer, U Julius, S Tselmin, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
U Julius, S Tselmin, U Schatz, et al.
European Journal of Epidemiology
|
August 2, 2003
Lipid-lowering therapy and cholesterol levels following acute myocardial infarction: a German study of 5361 patients
A Bergmann, J Schulze, D Hübner, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Mental symptoms and quality of life in lipoprotein apheresis patients in comparison to hemodialysis patients, platelet donors and normal population
E Stasiewski, M Christoph, A Christoph, et al.
Acta Diabetologica Latina
|
July 1, 1981
Hyperinsulinemia in patients with low fractional catabolic rate of triglycerides
U Julius, W Leonhardt, J Schulze, et al.
Annals of Clinical Research
|
January 1, 1988
More exercise for the hyperlipidaemic patients?
M Hanefeld, S Fischer, U Julius, et al.
Fortschritte Der Medizin
|
December 20, 1992
[Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia]
U Julius, C Hora, P Gross, et al.
Monographs on Atherosclerosis
|
January 1, 1985
The Diabetes Intervention Study (DIS): a cooperative multi-intervention trial with newly manifested type II diabetics: preliminary results
M Hanefeld, J Schulze, S Fischer, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Atherosclerosis. Supplements
|
January 30, 2013
Current situation of lipoprotein apheresis in Saxony
U Julius, K Taseva, S Fischer, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a)-an interdisciplinary challenge
U Julius, S Tselmin, U Schatz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 29, 2014
[Lipoprotein(a): a risk factor for atherosclerosis]
S Fischer, U Julius, S Tselmin, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
U Julius, S Tselmin, U Schatz, et al.
European Journal of Epidemiology
|
August 2, 2003
Lipid-lowering therapy and cholesterol levels following acute myocardial infarction: a German study of 5361 patients
A Bergmann, J Schulze, D Hübner, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Mental symptoms and quality of life in lipoprotein apheresis patients in comparison to hemodialysis patients, platelet donors and normal population
E Stasiewski, M Christoph, A Christoph, et al.
Acta Diabetologica Latina
|
July 1, 1981
Hyperinsulinemia in patients with low fractional catabolic rate of triglycerides
U Julius, W Leonhardt, J Schulze, et al.
Annals of Clinical Research
|
January 1, 1988
More exercise for the hyperlipidaemic patients?
M Hanefeld, S Fischer, U Julius, et al.
Fortschritte Der Medizin
|
December 20, 1992
[Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia]
U Julius, C Hora, P Gross, et al.
Monographs on Atherosclerosis
|
January 1, 1985
The Diabetes Intervention Study (DIS): a cooperative multi-intervention trial with newly manifested type II diabetics: preliminary results
M Hanefeld, J Schulze, S Fischer, et al.
Page
of 12